CSIMarket
 


Cytocore Inc  (CYOE)
Other Ticker:  
 

Cytocore Inc's Leverage Ratio

CYOE's quarterly Leverage Ratio and Total Liabilities, Equity growth


Due to repayements of liabilities of -4.66% Cytocore Inc improved Leverage Ratio in third quarter 2014 to 0.6, a new company low.

Within Laboratory Analytical Instruments industry in the third quarter 2014, 17 other companies have achieved lower Leverage Ratio than Cytocore Inc in the III Quarter 2014. While Leverage Ratio total ranking has improved so far in the third quarter 2014 to 1492, from total ranking in the second quarter 2014 at 1510 .

Explain Leverage Ratio?
Who are CYOE Customers?
What are CYOE´s Total Liabilities?


CYOE Leverage Ratio (Sep 30 2014)
III. Quarter
(Jun 30 2014)
II. Quarter
(Mar 31 2014)
I. Quarter
(Dec 31 2013)
IV. Quarter
(Sep 30 2013)
III. Quarter
Y / Y Equity Change - - - - -
Y / Y Total Liabilities Change 108.03 % 123.25 % -38.6 % -43.02 % -45.29 %
Leverage Ratio MRQ 0.6 0.63 - - -
CYOE's Total Ranking # 1492 # 1510 # 1510 # 0 # 0
Seq. Equity Change -0.23 % - - - -
Seq. Total Liabilities Change -4.66 % 89.24 % 5.66 % 9.13 % 2.31 %



Leverage Ratio third quarter 2014 Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 18
Healthcare Sector # 378
Overall Market # 1492


Leverage Ratio Statistics
High Average Low
0.63 0.61 0.6
(Jun 30 2014)   (Sep 30 2014)




Financial Statements
Cytocore Inc's Equity $ 14 Millions Visit CYOE's Balance sheet
Cytocore Inc's Total Liabilities $ 8 Millions Visit CYOE's Balance sheet
Source of CYOE's Sales Visit CYOE's Sales by Geography


Cumulative Cytocore Inc's Leverage Ratio

CYOE's Leverage Ratio for the trailling 12 Months

CYOE Leverage Ratio

(Sep 30 2014)
III. Quarter
(Jun 30 2014)
II. Quarter
(Mar 31 2014)
I. Quarter
(Dec 31 2013)
IV. Quarter
(Sep 30 2013)
III. Quarter
Y / Y Equity TTM Growth - - - - -
Y / Y Total Liabilities TTM Growth 108.03 % 123.25 % -38.6 % -43.02 % -45.29 %
Leverage Ratio TTM 1.38 21.18 - - -
Total Ranking TTM # 14 # 310 # 1510 # 3120 # 0
Seq. Equity TTM Growth -0.23 % - - - -
Seq. Total Liabilities TTM Growth -4.66 % 89.24 % 5.66 % 9.13 % 2.31 %


On the trailing twelve months basis Due to repayements of liabilities of -4.66% Cytocore Inc decreased Leverage Ratio in the 12 months ending in III Quarter 2014 to 1.38, a new company low.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Laboratory Analytical Instruments industry CYOE recorded the lowest Leverage Ratio. While Leverage Ratio total ranking has improved so far to 14, from total ranking in previous 12 month period at 310.

Explain Leverage Ratio?
Who are CYOE Customers?
What are CYOE´s Total Liabilities?

TTM Leverage Ratio Company Ranking
Within: No.
Within the Laboratory Analytical Instruments Industry # 0
Healthcare Sector # 2
Within the Market # 14


trailing twelve months Leverage Ratio Statistics
High Average Low
21.18 11.28 1.38
(Jun 30 2014)   (Sep 30 2014)




Companies with similar Leverage Ratio in the quarter ending Sep 30 2014, within Laboratory Analytical Instruments Industry Leverage RatioSep 30 2014 MRQ Total LiabilitiesSep 30 2014 MRQ Equity
Mettler toledo International Inc   1.48 $ 1,258.515  Millions$ 848.940  Millions
Illumina Inc   1.45 $ 1,848.813  Millions$ 1,274.313  Millions
Bruker Corporation  1.36 $ 1,103.100  Millions$ 813.100  Millions
Pacific Biosciences Of California Inc   1.29 $ 68.607  Millions$ 53.035  Millions
Metastat, Inc.  1.29 $ 1.071  Millions$ 0.829  Millions
Waters Corp  1.04 $ 1,909.856  Millions$ 1,841.820  Millions
Agilent Technologies inc   1.04 $ 5,476.000  Millions$ 5,284.000  Millions
Perkinelmer Inc  0.88 $ 1,823.716  Millions$ 2,062.754  Millions
Seer Inc   0.62 $ 4.197  Millions$ 6.724  Millions
Kewaunee Scientific Corporation  0.62 $ 22.242  Millions$ 36.092  Millions
Cytocore Inc  0.60 $ 8.184  Millions$ 13.657  Millions
Bio rad Laboratories Inc   0.56 $ 1,209.294  Millions$ 2,176.730  Millions
Scientific Industries Inc   0.47 $ 2.629  Millions$ 5.542  Millions
Erba Diagnostics, Inc.  0.43 $ 7.963  Millions$ 18.440  Millions
Harvard Bioscience Inc  0.41 $ 39.352  Millions$ 96.776  Millions
Thermogenesis Holdings Inc   0.30 $ 13.568  Millions$ 45.598  Millions
Eyepoint Pharmaceuticals Inc   0.22 $ 7.938  Millions$ 35.802  Millions
Lifeloc Technologies Inc   0.18 $ 0.854  Millions$ 4.872  Millions
Abaxis Inc  0.17 $ 33.550  Millions$ 202.080  Millions
Misonix Inc   0.16 $ 2.794  Millions$ 17.019  Millions

Date modified: 2023-03-23T00:17:47+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com